Myocardial Perfusion Echocardiography to Detect Human Heart Transplant Rejection

• Status: Unknown status
• Trial end date: 2019-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary objective of this proposal is to show the efficacy of contrast enhanced ultrasonography in detecting heart transplant rejection in humans. The secondary objective is to demonstrate the efficacy of this technique in generating data which allow for the assessment of short and long term outcomes.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Brigham and Women's Hospital
• Collaborator: General Electric

Criteria

Inclusion Criteria:

• All adult subjects (ages 18 to 75) who have undergone heart transplant at Brigham and Women's Hospital

Exclusion Criteria:

• hemodynamic instability (e.g., systolic blood pressure < 90 mmHg)

• atrial fibrillation with rapid ventricular response (e.g., heart rate > 120 bpm)

• premature atrial or ventricular complexes of a frequency that will not allow adequate echocardiographic assessment

• poor acoustic windows

• inability to provide informed consent

• any contraindication listed in the Optison package insert (i.e., history of an allergic reaction)